Which statement correctly identifies when a drug's labeling would be considered false or misleading?

When determining whether a drug's labeling is false or misleading, the focus is on the information presented about the drug itself, particularly regarding its effects and efficacy. If the labeling includes false information about a drug's effects, it misrepresents what the drug can do, which presents a significant risk to consumers and healthcare providers. Accurate labeling is essential for safe and effective medication use; misleading claims can lead to inappropriate use of the drug, adverse health consequences, and a breach of regulatory standards.

In contrast, the other options primarily relate to packaging and presentation rather than the accuracy of the information provided about the drug. Improper packaging or quantities may lead to concerns about compliance with regulations, but they do not directly address the truthfulness of the claims made about the drug's therapeutic effects. Therefore, the correct identification hinges on the veracity of the effects stated on the drug's label, making the first statement the one that correctly defines misleading labeling.